Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10457217 | 0.81 | TAAR1 (0.54) | HRH3SLC6A2SLC6A3ALDH1A1MAPT | |
| SCHEMBL5153023 | 0.81 | HRH3 (0.44) | HRH3CYP2C19 | |
| SCHEMBL15184685 | 0.81 | HRH3 (0.44) | HRH3CYP2C19 | |
| SCHEMBL13662800 | 0.81 | HRH3 (0.44) | HRH3CYP2C19 | |
| SCHEMBL22555722 | 0.80 | TSHR (0.42) | HRH3ALDH1A1MAPTCYP2C19CYP2C9 | |
| SCHEMBL10178994 | 0.80 | RIPK1 (0.39) | SLC6A2SLC6A3ALDH1A1MAPTCYP2C19 | |
| SCHEMBL867450 | 0.79 | AOC3 (0.47) | HRH3CYP2C19LMNAHIF1ATDP1 | |
| SCHEMBL21353855 | 0.79 | AOC3 (0.47) | HRH3SLC6A2CYP2C19SMN1; SMN2KDM4E | |
| SCHEMBL31379012 | 0.79 | ALDH1A1 (0.40) | ALDH1A1MAPTSTAT3CHRNA7CYP2C9 | |
| SCHEMBL15184752 | 0.79 | AOC3 (0.47) | HRH3CYP2C19LMNAHIF1ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260003210-A1 | DIFFRACTIVE CONTACT LENSES | ALCON INC (CH) | 2026-01-01 | — | — | US | claimed |
| US-12379611-B2 | Diffractive contact lenses | ALCON INC. (CH) | 2025-08-05 | — | — | US | claimed |
| CN-118085173-A | Underwater conductive anti-expansion flexible sensing material and preparation method thereof | 陕西科技大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117987121-A | Compound, polymer with fluidity regulation and interfacial activity, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| EP-4356169-A1 | MULTIFOCAL DIFFRACTIVE SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2024-04-24 | — | — | EP | claimed |
| CN-117280252-A | Multifocal diffractive silicone hydrogel contact lenses | 爱尔康公司 | 2023-12-22 | — | — | CN | claimed |
| CN-115583864-A | Preparation method of homoallylic alcohol compound | 哈尔滨工业大学（深圳） | 2023-01-10 | — | — | CN | claimed |
| US-20230004023-A1 | DIFFRACTIVE CONTACT LENSES | ALCON INC. (CH) | 2023-01-05 | — | — | US | claimed |
| WO-2022263994-A1 | MULTIFOCAL DIFFRACTIVE SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2022-12-22 | — | — | WO | claimed |
| US-20260133439-A1 | CONTACT LENSES WITH COLOR FILTERING ZONE | ALCON INC. (CH) | 2026-05-14 | — | — | US | disclosed |
| US-20260118700-A1 | DIFFRACTIVE MULTIFOCAL CONTACT LENS | ALCON INC (CH) | 2026-04-30 | — | — | US | disclosed |
| US-20260104598-A1 | COMPOSITE CONTACT LENSES WITH ULTRATHIN OBJECTS | ALCON INC (CH) | 2026-04-16 | — | — | US | disclosed |
| EP-4719753-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4719750-A1 | EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| US-20080293822-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | ETHISMOS RESEARCH, INC. | 2008-11-27 | — | — | US | disclosed |
| US-20080269348-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | ETHISMOS RESEARCH, INC. | 2008-10-30 | — | — | US | disclosed |
| US-20080194696-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | ETHISMOS RESEARCH, INC. | 2008-08-14 | — | — | US | disclosed |
| WO-2008057575-A2 | NOVEL ARYLBICYCLO[3.1.0]HEXYLAMINES AND METHODS AND COMPOSITIONS FOR THEIR PREPARATION AND USE | DOV PHARMACEUTICAL, INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| US-5190929-A | Cyclophosphamide derivatives | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-03-02 | — | — | US | disclosed |
| WO-1989011278-A1 | CYCLOPHOSPHAMIDE ANALOGS USEFUL AS ANTI-TUMOR AGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1989-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194696-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | HTR2C, HTR1B, HTR3C | HRH3 160/4885SLC6A2 150/4885SLC6A3 76/4885 |
| US-20260133439-A1 | CONTACT LENSES WITH COLOR FILTERING ZONE | MYO1G, STRA6, GJA1 | HRH3 2602/4885SLC6A2 3321/4885SLC6A3 2980/4885 |
| US-20080293822-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | HTR2C, HTR1B, HTR3C | HRH3 160/4885SLC6A2 150/4885SLC6A3 76/4885 |
| US-20260003210-A1 | DIFFRACTIVE CONTACT LENSES | LBR, CRYZ, CRYAA | HRH3 1450/4885SLC6A2 4503/4885SLC6A3 3914/4885 |
| US-20080269348-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | HTR2C, HTR1B, HTR3C | HRH3 160/4885SLC6A2 150/4885SLC6A3 76/4885 |
| US-20260104598-A1 | COMPOSITE CONTACT LENSES WITH ULTRATHIN OBJECTS | CRYZ, CRYAA, LIMA1 | HRH3 3685/4885SLC6A2 4795/4885SLC6A3 4683/4885 |
| US-20260118700-A1 | DIFFRACTIVE MULTIFOCAL CONTACT LENS | DSG1, SDC1, DSP | HRH3 4270/4885SLC6A2 4379/4885SLC6A3 3796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.